(Q43283843)

English

Increased risk of developing chronic HBV infection in infants born to chronically HBV infected mothers as a result of delayed second dose of hepatitis B vaccination

scientific article published on 27 August 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 November 2017

Increased risk of developing chronic HBV infection in infants born to chronically HBV infected mothers as a result of delayed second dose of hepatitis B vaccination (English)

1 reference

Europe PubMed Central

18 November 2017

Yong Poovorawan

5

1 reference

Europe PubMed Central

18 November 2017

Pattaratida Sa-nguanmoo

4

object named as

Pattaratida Sa-nguanmoo

1 reference

Europe PubMed Central

18 November 2017

Saowanee Plianpanich

3

object named as

Saowanee Plianpanich

1 reference

Europe PubMed Central

18 November 2017

author name string

Piyanit Tharmaphornpilas

1

1 reference

Europe PubMed Central

18 November 2017

Aim-orn Rasdjarmrearnsook

2

1 reference

Europe PubMed Central

18 November 2017

language of work or name

0 references

publication date

27 August 2009

1 reference

Europe PubMed Central

18 November 2017

1 reference

Europe PubMed Central

18 November 2017

27

1 reference

Europe PubMed Central

18 November 2017

6110-6115

1 reference

Europe PubMed Central

18 November 2017

44

1 reference

Europe PubMed Central

18 November 2017

Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.034

7 January 2021

Evidence against breast-feeding as a mechanism for vertical transmission of hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.034

7 January 2021

Risks of chronicity following acute hepatitis B virus infection: a review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.034

7 January 2021

Impact of hepatitis B immunisation as part of the EPI

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.034

7 January 2021

Prevalence of HBsAg mutants and impact of hepatitis B infant immunisation in four Pacific Island countries.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.034

7 January 2021

Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.034

7 January 2021

Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.034

7 January 2021

Hepatitis B seroprevalence in Thailand: 12 years after hepatitis B vaccine integration into the national expanded programme on immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.034

7 January 2021

Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.034

7 January 2021

Integration of hepatitis B vaccination into the expanded programme on immunization in Chonburi and Chiangmai provinces, Thailand

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.034

7 January 2021

Comparative evaluation of a combined DTP–HB vaccine in the EPI in Chiangrai Province, Thailand

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.034

7 January 2021

Comparison of a recombinant DNA hepatitis B vaccine alone or in combination with hepatitis B immune globulin for the prevention of perinatal acquisition of hepatitis B carriage

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.034

7 January 2021

Long term efficacy of hepatitis B vaccine in infants born to hepatitis B e antigen-positive mothers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.034

7 January 2021

Protective efficacy of hepatitis B vaccine without HBIG in infants of HBeAg-positive carrier mothers in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.034

7 January 2021

Simultaneous quantitation and genotyping of hepatitis B virus by real-time PCR and melting curve analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.034

7 January 2021

Molecular analysis of the a determinant of HBsAg in children of HBeAg-positive mothers upon failure of postexposure prophylaxis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.034

7 January 2021

Variants within the "a" Determinant of HBs Gene in Children and Adolescents with and without Hepatitis B Vaccination as Part of Thailand's Expanded Program on Immunization (EPI)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.034

7 January 2021

Long-term antibody persistence in children primed and boosted with a DTPw-HBV vaccine at 2, 4, 6, 18, months of age

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.08.034

7 January 2021

Identifiers

10.1016/J.VACCINE.2009.08.034

1 reference

Europe PubMed Central

18 November 2017

release_v7cairg2lzae3d26ktzme27inm

1 reference

https://api.fatcat.wiki/v0/release/v7cairg2lzae3d26ktzme27inm

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

18 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43283843&oldid=2120225074"